127 related articles for article (PubMed ID: 27826993)
1. Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure.
Bytzer P; Reimer C; Smith G; Anatchkova MD; Hsieh R; Wilkinson J; Thomas SJ; Lenderking WR
Scand J Gastroenterol; 2017 Mar; 52(3):276-283. PubMed ID: 27826993
[TBL] [Abstract][Full Text] [Related]
2. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
Coyle C; Crawford G; Wilkinson J; Thomas SJ; Bytzer P
Aliment Pharmacol Ther; 2017 Jun; 45(12):1524-1533. PubMed ID: 28464343
[TBL] [Abstract][Full Text] [Related]
3. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors.
Rydén A; Denison H; Karlsson M; Vakil N
Scand J Gastroenterol; 2013 Sep; 48(9):1018-26. PubMed ID: 23919738
[TBL] [Abstract][Full Text] [Related]
5. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor.
Reimer C; Lødrup AB; Smith G; Wilkinson J; Bytzer P
Aliment Pharmacol Ther; 2016 Apr; 43(8):899-909. PubMed ID: 26909885
[TBL] [Abstract][Full Text] [Related]
6. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
Kahrilas PJ; Hughes N; Howden CW
Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
[TBL] [Abstract][Full Text] [Related]
7. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
[TBL] [Abstract][Full Text] [Related]
8. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
[TBL] [Abstract][Full Text] [Related]
9. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.
Bardhan KD; Stanghellini V; Armstrong D; Berghöfer P; Gatz G; Mönnikes H
Digestion; 2007; 75 Suppl 1():48-54. PubMed ID: 17489032
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
Dent J; Vakil N; Jones R; Bytzer P; Schöning U; Halling K; Junghard O; Lind T
Gut; 2010 Jun; 59(6):714-21. PubMed ID: 20551454
[TBL] [Abstract][Full Text] [Related]
11. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire.
van Zanten SV; Armstrong D; Barkun A; Junghard O; White RJ; Wiklund IK
Aliment Pharmacol Ther; 2007 May; 25(9):1087-97. PubMed ID: 17439510
[TBL] [Abstract][Full Text] [Related]
12. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.
Jones R; Horbach S; Sander P; Rydén-Bergsten T
Pharmacoeconomics; 2003; 21(15):1091-102. PubMed ID: 14596628
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Reflux Disease Questionnaire for a German population.
Nocon M; Kulig M; Leodolter A; Malfertheiner P; Willich SN
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):229-33. PubMed ID: 15674102
[TBL] [Abstract][Full Text] [Related]
14. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
15. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
16. Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
Toghanian S; Johnson DA; Stålhammar NO; Zerbib F
Clin Drug Investig; 2011 Oct; 31(10):703-15. PubMed ID: 21756007
[TBL] [Abstract][Full Text] [Related]
17. Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.
Ekesbo R; Sjöstedt S; Sörngård H
Clin Drug Investig; 2011; 31(3):181-9. PubMed ID: 21288053
[TBL] [Abstract][Full Text] [Related]
18. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
Kahrilas PJ; Boeckxstaens G
Gut; 2012 Oct; 61(10):1501-9. PubMed ID: 22684485
[TBL] [Abstract][Full Text] [Related]
19. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
Bytzer P; van Zanten SV; Mattsson H; Wernersson B
Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
Nakada K; Matsuhashi N; Iwakiri K; Oshio A; Joh T; Higuchi K; Haruma K
World J Gastroenterol; 2017 Jul; 23(28):5216-5228. PubMed ID: 28811716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]